Clinical Trial

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-02.
Status change: Not Yet Recruiting → Recruiting 2026-04-19
Trial Details
NCT Number NCT06485505
Lead Sponsor Zagazig University
Conditions Onychomycosis
Enrollment 36 participants
Start Date 2024-07-12
Primary Completion 2026-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-23